Background:

The Complainant had been employed by the Respondent, a pharmaceutical manufacturer, since August 2018 as the Respondent’s Pharmacovigilance Manager. This meant the Complainant’s role was to advise the Respondent in the detection, assessment, understanding and prevention of adverse events in the medicines they produced.

The Complainant uncovered a marketing communication issued by the Respondent which was drafted in a way which had the potential to confuse and mislead client pharmacies into believing they were reading patent information materials. This marketing information was formatted and written as though they were patent information material, but excluded some language about patient risk which would have been otherwise required by law. The Complainant raised this to the Respondent, ultimately causing the Respondent